Levocarnitine for valproate-induced hyperammonemia in the psychiatric setting: A case series and literature review

INTRODUCTION: Hyperammonemia is a potential adverse effect of valproic acid (VPA) therapy, which is often asymptomatic but can lead to severe, life-threatening encephalopathy. Carnitine deficiency due to VPA is the proposed mechanism for hyperammonemia and the development of VPA-induced hyperammonem...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:Ment Health Clin
Main Authors: Brown, Lauren M., Cupples, Nicole, Moore, Troy A.
Format: Artigo
Sprog:Inglês
Udgivet: College of Psychiatric & Neurologic Pharmacists 2018
Fag:
Case Reports
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC6007637/
https://ncbi.nlm.nih.gov/pubmed/29955560
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.9740/mhc.2018.05.148
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker